Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Endoscopic transsphenoidal surgery for cushing disease: techniques, outcomes, and predictors of remission.

Starke RM, Reames DL, Chen CJ, Laws ER, Jane JA Jr.

Neurosurgery. 2013 Feb;72(2):240-7; discussion 247. doi: 10.1227/NEU.0b013e31827b966a.

PMID:
23149974
2.

Pure endoscopic transsphenoidal surgery for functional pituitary adenomas: outcomes with Cushing's disease.

Sarkar S, Rajaratnam S, Chacko G, Mani S, Hesargatta AS, Chacko AG.

Acta Neurochir (Wien). 2016 Jan;158(1):77-86; discussion 86. doi: 10.1007/s00701-015-2638-7. Epub 2015 Nov 17.

PMID:
26577636
3.

Impact of technique on cushing disease outcome using strict remission criteria.

Alahmadi H, Cusimano MD, Woo K, Mohammed AA, Goguen J, Smyth HS, Macdonald RL, Muller PJ, Horvath E, Kovacs K.

Can J Neurol Sci. 2013 May;40(3):334-41.

PMID:
23603168
5.

Outcome of Microscopic Transsphenoidal Surgery in Cushing Disease: A Case Series of 96 Patients.

Shirvani M, Motiei-Langroudi R, Sadeghian H.

World Neurosurg. 2016 Mar;87:170-5. doi: 10.1016/j.wneu.2015.11.046. Epub 2015 Dec 17.

PMID:
26704208
6.

Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.

Fomekong E, Maiter D, Grandin C, Raftopoulos C.

Clin Neurol Neurosurg. 2009 Jun;111(5):442-9. doi: 10.1016/j.clineuro.2008.12.011. Epub 2009 Feb 5.

PMID:
19200645
7.

Outcome of Transsphenoidal Surgery for Cushing Disease: A Single-Center Experience Over 32 Years.

Chandler WF, Barkan AL, Hollon T, Sakharova A, Sack J, Brahma B, Schteingart DE.

Neurosurgery. 2016 Feb;78(2):216-23. doi: 10.1227/NEU.0000000000001011.

PMID:
26348007
8.

Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.

Hameed N, Yedinak CG, Brzana J, Gultekin SH, Coppa ND, Dogan A, Delashaw JB, Fleseriu M.

Pituitary. 2013 Dec;16(4):452-8. doi: 10.1007/s11102-012-0455-z.

PMID:
23242860
9.

Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease.

Rollin G, Ferreira NP, Czepielewski MA.

Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1355-61.

10.

Primary Endoscopic Transnasal Transsphenoidal Surgery for Magnetic Resonance Image-Positive Cushing Disease: Outcomes of a Series over 14 Years.

Kuo CH, Yen YS, Wu JC, Chen YC, Huang WC, Cheng H.

World Neurosurg. 2015 Sep;84(3):772-9. doi: 10.1016/j.wneu.2015.04.059. Epub 2015 May 7.

PMID:
25957728
11.

Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD).

Wagenmakers MA, Netea-Maier RT, van Lindert EJ, Timmers HJ, Grotenhuis JA, Hermus AR.

Clin Endocrinol (Oxf). 2009 Feb;70(2):274-80. doi: 10.1111/j.1365-2265.2008.03334.x.

PMID:
18616702
12.

Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing's disease.

Netea-Maier RT, van Lindert EJ, den Heijer M, van der Eerden A, Pieters GF, Sweep CG, Grotenhuis JA, Hermus AR.

Eur J Endocrinol. 2006 May;154(5):675-84.

13.

Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission.

Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA Jr.

J Clin Endocrinol Metab. 2013 Aug;98(8):3190-8. doi: 10.1210/jc.2013-1036. Epub 2013 Jun 4.

PMID:
23737543
14.

[Cushing disease: long-term follow-up after transsphenoidal surgery].

Benbassat CA, Tsvetov G, Shefet D, Weinstein R, Rappaport ZH.

Harefuah. 2004 Sep;143(9):636-8, 696, 695. Hebrew.

PMID:
15521676
15.

Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients.

Shimon I, Ram Z, Cohen ZR, Hadani M.

Neurosurgery. 2002 Jul;51(1):57-61; discussion 61-2.

PMID:
12182435
16.

Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts.

McLaughlin N, Cohan P, Barnett P, Eisenberg A, Chaloner C, Kelly DF.

World Neurosurg. 2013 Nov;80(5):569-75. doi: 10.1016/j.wneu.2012.07.034. Epub 2012 Aug 14.

PMID:
22902358
17.

Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?

Chee GH, Mathias DB, James RA, Kendall-Taylor P.

Clin Endocrinol (Oxf). 2001 May;54(5):617-26.

PMID:
11380492
18.

Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.

Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws ER Jr.

Neurosurgery. 2008 Aug;63(2):266-70; discussion 270-1. doi: 10.1227/01.NEU.0000313117.35824.9F.

PMID:
18797356
19.

Cushing disease in children and adolescents: twenty years' experience in a tertiary care center in India.

Shah NS, George J, Acharya SV, Lila AR, Sarathi V, Bandgar TR, Jalali R, Goel AH, Menon P.

Endocr Pract. 2011 May-Jun;17(3):369-76. doi: 10.4158/EP10143.OR.

PMID:
21134883
20.

Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.

Yap LB, Turner HE, Adams CB, Wass JA.

Clin Endocrinol (Oxf). 2002 Jan;56(1):25-31.

PMID:
11849243

Supplemental Content

Support Center